Stock screenerAll disclosures → EDGAR →
BDSX
Conviction 97HealthcareScan · Thu, Jun 25, 2026BDSX$20.18+8.09%
ResistanceSupportVol 14Vol MA14 146.87K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price20.18
Change+8.09%
Gap+3.13%
Rel volume17.95×
Avg volume121.59K
Avg $ vol2.21M
SMA 2016.23
SMA 5014.47
SMA 20010.84
Price vs 50+39.44%
Price vs 200+86.20%
MA stackbullish
50/200 cross—
Supertrendup · 15.97
RSI (14)73
MACD hist0.43
MACD crossbull · 4d
Stoch %K / %D75 / 84
ADX (14)27
+DI / −DI36 / 8
RSI divergence—
MACD divergence—
ATR %+7.14%
ADR %7.76%
52w high20.18
52w low0.2503
From 52w high+0.00%
Above 52w low+7962.33%
New 52w highYes
SqueezeOff
Bollinger width36.37%
%B1.17
Donchian pos75.17%
Donchian high22.02
Donchian low14.61
AVWAP (52w high)20.48
vs AVWAP high-1.46%
AVWAP (52w low)3.76
vs AVWAP low+436.39%
OBV trendUp
Chaikin MF (20)-0.28
Today vs 20d17.95×
Avg vol (14d)146.87K
Avg vol (20d)121.59K
Avg $ vol (20d)2.21M
Market cap203.99M
RS 3m (vs SPY)+7.88%
RS 6m (vs SPY)+171.34%
RS line new highNo
Trend template8/8
Technical rank97.0
1 week+32.59%
1 month+36.26%
3 months+33.20%
6 months+196.33%
1 year+7232.85%
YTD+212.38%
P/E-5.78
P/B22.34
P/S2.31
P/FCF-8.67
EPS-4.67
Div yield—
ROE-386.17%
ROA-37.26%
Debt/Eq5.48
Current2.82
EV/EBITDA-10.29
Gross margin—
Net margin-39.85%
Rev growth24.08%
EPS growth17.86%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value228.42M
Revenue25.55M
Net income-7.79M
Gross profit—
Free cash flow-23.53M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out10.36M
Employees334
ListedWed, Oct 28, 2020
Free float4.95M
Float %49.2%
Short interest106.46K
Days to cover2.3d
Short volume31.3%
Squeeze score31 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.85 · 2 est
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction97 / 100
Pattern quality—
Tech rank97.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.96
Support13.87
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BDSX
No recent disclosed trades by Congress in BDSX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BDSX
No recent insider (Form 4) filings in BDSX. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in BDSX · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.